RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1710-1720

  Liu, Zhikui ^a   Dou, Changwei ^a   Jia, Yuli ^a   Li, Qing ^a   Zheng, Xin ^a   Yao, Yingmin ^a   Liu, Qingguang ^a   Song, Tao ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

hepatocellular carcinoma; interferon therapeutic response; matrix metalloproteinase 9; Retinoic acid induced protein I

Indexed keywords

ALPHA INTERFERON; GELATINASE B; JANUS KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; SYNAPSIN I; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; MMP9 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; FEMALE; HEPATOCELLULAR CARCINOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION; ANIMAL; CANCER TRANSPLANTATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DOWN-REGULATION; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84923112461     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2853     Document Type: Article

References (32)

1. EL-SERAG HB and RUDOLPH KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. LEVINE AJ and PUZIO-KUTER AM: The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344, 2010.
3. KATO H, SATO S, YONEYAMA M, et al: Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28, 2005.
4. BESCH R, POECK H, HOHENAUER T, et al: Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119: 2399-2411, 2009.
5. SUN HC, TANG ZY, WANG L, et al: Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: A randomized clinical trial. J Cancer Res Clin Oncol 132: 458-465, 2006.
6. CLAVIEN PA: Interferon: The magic bullet to prevent hepatocellular carcinoma recurrence after resection? Ann Surg 245: 843-845, 2007.
7. TANIGUCHI T and TAKAOKA A: A weak signal for strong responses: Interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386, 2001.
8. DER SD, ZHOU A, WILLIAMS BR and SILVERMAN RH: Identifcation of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci uSA 95: 15623-15628, 1998.
9. SCHINDLER C, SHUAI K, PREZIOSO VR and DARNELL JE Jr: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813, 1992.
10. HEINRICH PC, BEHRMANN I, HAAN S, HERMANNS HM, MULLER-NEWEN G and SCHAPER F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
11. CHAWLA-SARKAR M, LINDNER DJ, LIU YF, et al: Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis. Apoptosis: An international journal on programmed Cell death 8: 237-249, 2003.
12. BROMBERG J: Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142, 2002.
13. YU H, KORTYLEWSKI M and PARDOLL D: Crosstalk between Cancer and immune cells: Role of STAT3 in the tumour microenviron-ment. Nat Rev Immunol 7: 41-51, 2007.
14. JONASCH E and HALUSKA FG: Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities. oncologist 6: 34-55, 2001.
15. BEKISZ J, BARON S, BALINSKY C, MORROW A and ZOON KC: Antiproliferative properties of type I and type II interferon. Pharmaceuticals 3: 994-1015, 2010.
16. RAO JS, YAMAMOTO M, MOHAMAN S, et al: Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12-18, 1996.
17. LIOTTA LA, TRYGGVASON K, GARBISA S, HART I, FOLTZ CM and SHAFE S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
18. HOU J, ZHOU Y, ZHENG Y, et al: Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma. Cancer Cell 25: 49-63, 2014.
19. EGEBLAD M and WERB Z: New functions for the matrix metal-loproteinases in Cancer progression. Nat Rev Cancer 2: 161-174, 2002.
20. BJORKLUND M and KOIVUNEN E: Gelatinase-mediated migration and invasion of Cancer cells. Biochim Biophys Acta 1755: 37-69, 2005.
21. LAMAR JM, PUMIGLIA KM and DIPERSIO CM: An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor Cell invasion. Cancer Res 68: 7371-7379, 2008.
22. UGARTE-BERZAL E, REDONDO-MUNOZ J, EROLES P, et al: VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia Cell migration. Blood 115: 846-849, 2010.
23. MA Z, QIN H and BENVENISTE EN: Transcriptional suppression of matrix metalloproteinase-9 Gene expression by IFN-gamma and IFN-beta: Critical role of STAT-1alpha. J Immunol 167: 5150-5159, 2001.
24. YEN JH, KONG W and GANEA D: IFN-beta inhibits dendritic Cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol 184: 3478-3486, 2010.
25. BRUIX J, SHERMAN M and AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASE: Management of hepatocellular carcinoma: An update. Hepatology 53: 1020-1022, 2011.
26. LEE JS, CHU IS, HEO J, et al: Classification and prediction of survival in hepatocellular carcinoma by Gene expression profling. Hepatology 40: 667-676, 2004.
27. BUDHU A, JIA HL, FORGUES M, et al: Identifcation of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907, 2008.
28. DERYUGINA EI and QUIGLEY JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
29. FINGLETON B: Matrix metalloproteinases: Roles in Cancer and metastasis. Front Biosci 11: 479-491, 2006.
30. KESSENBROCK K, PLAKS V and WERB Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
31. YANG P, YUAN W, HE J, et al: Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis. Hepatol Res 39: 1169-1177, 2009.
32. TAKEUCHI O and AKIRA S: Pattern recognition receptors and infammation. Cell 140: 805-820, 2010.